Research shows that urolithin A, a natural compound from berries and pomegranates, significantly reduced liver fat, inflammation, and cellular damage in rats fed high-fat diets. According to Gram Research analysis, the compound activated protective pathways in liver cells and reduced markers of liver scarring by modulating oxidative stress and inflammatory responses. While these findings are promising, human studies are needed before urolithin A can be recommended as a treatment for fatty liver disease.
Researchers discovered that urolithin A, a natural compound found in berries and pomegranates, may protect the liver from damage caused by eating high-fat diets. In a study with rats, urolithin A reduced liver fat buildup, decreased inflammation, and lowered oxidative stress (cellular damage from harmful molecules). The compound worked by activating protective pathways in liver cells. According to Gram Research analysis, this finding suggests urolithin A could become a new treatment option for metabolic dysfunction-associated steatotic liver disease (MASLD), a condition where fat accumulates in the liver and causes damage.
Key Statistics
A 2026 animal study published in Cell Biochemistry and Function found that urolithin A reduced liver fat accumulation and decreased inflammatory markers in rats fed high-fat diets for 12 weeks compared to rats receiving high-fat diet alone.
The study showed that urolithin A activated two protective liver pathways, FXR and PPAR-alpha, while reducing oxidative stress markers and fibrotic indicators in liver tissue of high-fat diet-fed rats.
Microscopic examination revealed that rats receiving urolithin A with high-fat diet showed significantly reduced liver cell death markers and decreased activation of liver scarring cells compared to high-fat diet controls.
The Quick Take
- What they studied: Whether a natural berry compound called urolithin A could prevent liver damage in animals fed a high-fat diet
- Who participated: Laboratory rats divided into four groups: a control group eating normal food, a group receiving urolithin A with normal food, a group eating high-fat food, and a group eating high-fat food plus urolithin A. The study lasted 12 weeks
- Key finding: Rats that received urolithin A while eating high-fat food had significantly less liver fat, lower inflammation markers, and reduced cellular damage compared to rats eating high-fat food alone
- What it means for you: This research suggests urolithin A from berries and pomegranates might help protect your liver if you eat a high-fat diet, though human studies are needed before making dietary changes. Talk to your doctor before taking supplements
The Research Details
Researchers used laboratory rats to test whether urolithin A could prevent liver disease caused by high-fat diets. They created four groups of rats: one eating normal food as a control, one getting urolithin A injections with normal food, one eating a high-fat diet, and one eating a high-fat diet plus urolithin A injections. The high-fat diet lasted 12 weeks to develop liver disease similar to what happens in humans. Urolithin A was given by injection four times per week at a dose of 2.5 milligrams per kilogram of body weight.
After the 12-week period, researchers measured many different markers of liver health. They checked body weight, fat tissue amount, liver size, liver enzymes in the blood (which indicate liver damage), cholesterol and triglyceride levels, oxidative stress markers (molecules that damage cells), inflammatory proteins, and genes related to liver protection. They also examined liver tissue under a microscope to see the actual damage and used special staining techniques to identify specific proteins involved in inflammation and cell death.
This type of study design is called a controlled animal experiment. It allows researchers to carefully control all variables and see cause-and-effect relationships that would be difficult to study in humans.
This research approach matters because it lets scientists understand exactly how urolithin A works to protect the liver. By measuring multiple markers at the same time, researchers can see the complete picture of how the compound affects different aspects of liver disease. The combination of blood tests, tissue examination, and gene expression analysis provides strong evidence for the mechanisms involved
Strengths of this study include the controlled environment where all variables can be carefully managed, the use of multiple measurement methods to confirm findings, and the examination of both molecular changes and actual tissue damage. Limitations include that this is an animal study, so results may not directly apply to humans. The sample size appears relatively small, and the study was conducted in a laboratory setting rather than real-world conditions. Additionally, the study did not test different doses or durations to find optimal treatment parameters
What the Results Show
Rats fed a high-fat diet developed significant liver disease, showing increased body weight, liver enlargement, elevated liver enzymes in the blood, high cholesterol and triglycerides, and visible fat accumulation in liver tissue. When urolithin A was added to the high-fat diet, these harmful changes were substantially reduced. The compound decreased liver fat buildup, lowered liver enzyme levels (indicating less damage), and improved cholesterol profiles.
Urolithin A also reduced oxidative stress, which is cellular damage caused by harmful molecules called free radicals. The compound decreased inflammatory proteins in the liver, including tumor necrosis factor alpha (TNF-alpha), a key inflammatory messenger. Microscopic examination showed that livers treated with urolithin A had less fat accumulation, fewer inflammatory cells, and reduced signs of cell death compared to livers damaged by high-fat diet alone.
At the molecular level, urolithin A activated two important protective pathways in liver cells: the FXR pathway and the PPAR-alpha pathway. These pathways help regulate fat metabolism and reduce inflammation. The compound also reduced markers of liver fibrosis, which is scarring that occurs when the liver is chronically damaged. This suggests urolithin A may prevent progression from fatty liver to more severe liver disease.
The study found that urolithin A reduced expression of Bax, a protein that triggers cell death, suggesting the compound protects liver cells from dying. It also decreased expression of glial fibrillary acidic protein (GFAP), which indicates reduced activation of liver support cells that contribute to scarring. These secondary findings support the idea that urolithin A works through multiple protective mechanisms rather than just one pathway
Previous research showed that urolithin A has anti-inflammatory and antioxidant properties in other tissues and diseases. This study extends those findings specifically to liver disease caused by high-fat diets. The results align with earlier research suggesting that compounds from berries and pomegranates have protective effects on liver health. However, this is one of the first studies to comprehensively examine how urolithin A affects multiple liver disease pathways simultaneously
The most important limitation is that this study used rats, not humans. Rat livers may respond differently to urolithin A than human livers. The study did not test whether urolithin A works if given after liver disease develops, only whether it prevents disease when given during high-fat feeding. The researchers did not test different doses to find the optimal amount. The study duration was 12 weeks, which is relatively short for understanding long-term effects. Additionally, the study did not compare urolithin A to existing liver disease treatments, so we cannot say whether it works better or worse than current options
The Bottom Line
Based on this animal research, urolithin A shows promise as a potential liver-protective compound. However, human studies are needed before making recommendations. Do not take urolithin A supplements specifically for liver disease without consulting your doctor. If you eat a high-fat diet, the most evidence-based approach remains reducing fat intake, maintaining a healthy weight, and exercising regularly. Eating foods naturally containing urolithin A, such as berries and pomegranates, is generally safe and may provide other health benefits
This research is most relevant to people with fatty liver disease, those at risk for developing it (including people who are overweight or have metabolic syndrome), and researchers studying liver disease treatments. It is less immediately relevant to people with healthy livers eating balanced diets. Healthcare providers treating liver disease should be aware of this research as a potential future treatment option
In this animal study, changes appeared over 12 weeks of treatment. If urolithin A eventually becomes a human treatment, benefits would likely take weeks to months to appear, similar to other liver disease treatments. Liver damage typically develops over years, so prevention or early treatment would be more effective than treating advanced disease
Frequently Asked Questions
Can urolithin A treat fatty liver disease in humans?
This study was conducted in rats, not humans. While results are promising, human clinical trials are needed to determine if urolithin A is safe and effective for treating fatty liver disease. Do not use supplements without consulting your doctor
What foods contain urolithin A naturally?
Urolithin A comes from ellagitannins found in berries, pomegranates, walnuts, and some other plant foods. Your gut bacteria convert these compounds into urolithin A. Eating these foods regularly may provide health benefits, though the amount of urolithin A produced varies between individuals
How does urolithin A protect the liver from fat damage?
According to this research, urolithin A works through multiple mechanisms: it reduces oxidative stress (cellular damage from harmful molecules), decreases inflammation, activates protective genes (FXR and PPAR-alpha), and prevents liver cell death and scarring
Should I take urolithin A supplements if I have a fatty liver?
This animal study does not provide enough evidence to recommend supplements. Talk to your doctor before starting any supplement. Proven approaches include losing weight, reducing high-fat foods, exercising regularly, and limiting alcohol. Your doctor can recommend appropriate treatments based on your specific condition
How long would it take to see benefits from urolithin A?
In this rat study, changes appeared over 12 weeks. If urolithin A becomes a human treatment, benefits would likely take weeks to months. Liver disease develops over years, so early prevention or treatment would be more effective than treating advanced disease
Want to Apply This Research?
- Track daily berry and pomegranate consumption in grams, along with weekly liver enzyme test results if available from your doctor. Monitor energy levels and any digestive changes as indirect markers of liver health
- Add one serving of berries or pomegranate (about 100 grams) to your daily diet. Log this in your food tracking app and note any changes in how you feel over 4 to 8 weeks. Combine this with reducing high-fat foods and increasing physical activity
- Create a monthly reminder to log your berry consumption and any symptoms like fatigue or digestive issues. If you have fatty liver disease, ask your doctor about tracking liver enzyme levels every 3 to 6 months to see if dietary changes are helping
This article summarizes animal research and should not be interpreted as medical advice. Urolithin A has not been approved by the FDA for treating any disease in humans. If you have fatty liver disease or are concerned about liver health, consult your healthcare provider before making dietary changes or taking supplements. This research is preliminary and human clinical trials are needed before urolithin A can be recommended as a treatment. Do not stop or replace prescribed medications based on this information.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.